| For: | He XD, Li M, Zuo XD, Ni HY, Han YX, Hu YK, Yu J, Yang XX. Kushenol I combats ulcerative colitis via intestinal barrier preservation and gut microbiota optimization. World J Gastroenterol 2025; 31(26): 105656 [PMID: 40678703 DOI: 10.3748/wjg.v31.i26.105656] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i26/105656.htm |
| Number | Citing Articles |
| 1 |
Jihao Yang, Junwen Wang, Jia Li, Shuo Yang. Lung-gut axis, intestinal microbiota, and pulmonary fibrosis: mechanisms and therapeutic potential. Frontiers in Microbiology 2025; 16 doi: 10.3389/fmicb.2025.1711299
|
| 2 |
Hao Cai, Meng-Ying Huang, Fang-Fang Mou, Qiang-Li Wang, Zhi-Rong Luo, Ping-Ping Lu, Bao-Nian Liu, Liang Hu, Hai-Dong Guo. NGR1 Pretreatment Enhances the Therapeutic Efficacy of Transplanting Cardiomyocytes Derived from Human Induced Pluripotent Stem Cells for Myocardial Infarction. International Journal of Molecular Sciences 2026; 27(1): 475 doi: 10.3390/ijms27010475
|
| 3 |
Canglin Li, Zuoqiang Li, Ya Zheng. Natural products targeting the MAPK signaling pathway: potential options for ulcerative colitis treatment. Frontiers in Pharmacology 2026; 16 doi: 10.3389/fphar.2025.1721584
|
| 4 |
Jihao Yang, Kai Xiong, Tengzhen Li, Morang Zhang, Zhangyun Li, Zhili Wen, Yuchuan Jiang. Anti-inflammatory effects of natural polysaccharides: molecular mechanisms and nanotherapeutic applications. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1723346
|
